FDA ApprovedUnited States
New Prescription Ointment for Mild-to-Moderate Eczema Ages 2 and Up
Adquey (difamilast) — topical ointment for mild-to-moderate eczema (atopic dermatitis)
FDA approved Adquey (difamilast) ointment, 1% on 12 February 2026 (NDA 219474) for topical treatment of mild to moderate atopic dermatitis in adults and…
This is for people with mild to moderate atopic dermatitis (eczema) — and caregivers of children 2 years and older — who may be candidates for labelled US…